An inhibitor of the mitotic kinase, MPS1, is selective towards pancreatic cancer cells
Indiana University-Purdue University Indianapolis (IUPUI). === The abysmal five year pancreatic cancer survival rate of less than 6% highlights the need for new treatments for this deadly malignancy. Cytotoxic drugs normally target rapidly dividing cancer cells but unfortunately often target stem ce...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1805/6184 |